Home - Products - Membrane Transporter/Ion Channel - Sodium Channel - Ralitoline

Ralitoline

CAS No. 1089085-40-4

Ralitoline( —— )

Catalog No. M34390 CAS No. 1089085-40-4

Ralitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	198	Get Quote
5MG	304	Get Quote
10MG	456	Get Quote
25MG	723	Get Quote
50MG	994	Get Quote
100MG	1332	Get Quote
500MG	2664	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Ralitoline
Note

Research use only, not for human use.
Brief Description

Ralitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.
Description

Ralitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Membrane Transporter/Ion Channel
Target

Sodium Channel
Recptor

Sodium Channel
Research Area

——
Indication

——

Chemical Information

CAS Number

1089085-40-4
Formula Weight

296.77
Molecular Formula

C13H13ClN2O2S
Purity

>98% (HPLC)
Solubility

——
SMILES

C(C(NC1=C(C)C=CC=C1Cl)=O)=C2N(C)C(=O)CS2
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

SPX-101

SPX-101 is a specific, peptide mimetic promoter of epithelial sodium channel (ENaC) internalization.
Strictosamide

Strictosamide possesses antibacterial and antiviral activities, it also may have important effects on inflammation and inflammatory pain.
PF-04531083

PF-04531083 (PF 4531083) is a potent and selective, orally available sodium channel Nav1.8 blocker for treatment of pain.

Sign In Join Free